Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

13.75
Delayed Data
As of 11:55am ET
 -0.53 / -3.71%
Today’s Change
5.34
Today|||52-Week Range
19.43
+125.41%
Year-to-Date

Today’s Trading

Previous close14.28
Today’s open14.08
Day’s range13.73 - 14.44
Volume454,207
Average volume (3 months)1,586,508
Market cap$1.2B
Dividend yield--
Data as of 11:55am ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-100.66%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book35.22

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-2.21-4.21%
AXONAxovant Sciences Ltd+0.20+1.68%
ATRAAtara Biotherapeutic...+1.48+3.68%
CHRSCoherus BioSciences ...-0.49-1.69%
Data as of 12:09pm ET, 08/31/2015

Financials

Next reporting dateOctober 23, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers